Ceapro Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | Ceapro Inc.

Ceapro Inc. | Cash Flow

Fiscal year is January-December. All values CAD Thousands.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

175.80

1,593.80

4,922.20

3,619.90

958.30

315.50

Depreciation, Depletion & Amortization

292.60

296.40

392.30

359.50

326.10

578.60

Other Funds

1,543.10

34.60

131.30

196.60

615.30

291.20

Funds from Operations

540.40

2,021.70

4,845.80

5,391.40

585.00

47.20

Changes in Working Capital

50.40

421.70

863.40

643.40

988.10

2,075

Net Operating Cash Flow

490.00

2,443.40

3,982.40

4,748.00

1,573.00

2,122.10

Capital Expenditures

2,303.40

4,619.90

4,205.80

4,844.00

4,018.60

Sale of Fixed Assets & Businesses

45.00

Net Investing Cash Flow

2,340.30

4,619.90

3,477.30

5,975.20

4,581.00

Issuance/Reduction of Debt, Net

1,987.10

389.10

948.90

1,061.20

1,097.50

Net Financing Cash Flow

3,530.20

496.30

903.20

8,696.20

31.80

Net Change in Cash

1,679.90

1,680.20

1,408.30

7,468.90

2,976.10

Free Cash Flow

1,813.30

2,176.50

223.40

96.00

2,445.60

Deferred Taxes & Investment Tax Credit

1,321.50

540.80

601.40

Net Assets from Acquisitions

646.70

Other Sources

728.50

128.30

Change in Capital Stock

141.80

85.60

9,560.80

514.00

Other Uses

36.90

1,131.20

88.90

About Ceapro

View Profile

Address	7824-51 Avenue NW Edmonton Alberta T6E 6W2 Canada
Employees	-
Website	http://www.ceapro.com
Updated	07/08/2019
Ceapro, Inc. is a biotechnology company, which is involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its extracts are also used in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company specializes in natural product chemistry, microbiology, biochemistry, immunology, and process engineering in the fields of active ingredients, biopharmaceuticals, and drug-delivery solutions.